Evidence-Based Mental Health
July 12, 2022
Darren Dunning, Kate Tudor, Lucy Radley et al.
Question: Mindfulness-based programmes (MBPs) are an increasingly popular approach to improving mental health in young people. Our previous meta-analysis suggested that MBPs show promising effectiveness, but highlighted a lack of high-quality, adequately powered randomised controlled trials (RCTs). This updated meta-analysis assesses the-state-of the-art of MBPs for young people in light of new...
Evidence-Based Mental Health
January 23, 2019
Eve-Ling Khoo, Rebecca Small, Wei Cheng et al.
Question This review compares mindfulness-based stress reduction (MBSR) to cognitive-behavioural therapy (CBT) in its ability to improve physical functioning and reduce pain intensity and distress in patients with chronic pain (CP), when evaluated against control conditions. Study selection and analysis Ovid MEDLINE, EmbaseClassic+Embase, PsycINFO and the Cochrane Library were searched to...
Evidence-Based Mental Health
August 4, 2018
Hilary Norman, Lisa Marzano, Mark Coulson et al.
131 citations
Question Alexithymia has been found to be modifiable through treatment, with associated clinical benefits. Recent studies have begun to test the potential of mindfulness-based interventions to reduce alexithymia, using skills-based, group training to improve non-judgemental, present-moment awareness. The objective of this review therefore was to conduct a systematic synthesis to assess the...
Evidence-Based Mental Health
August 2018
Junhua Zhang, Amparo Díaz-Román, Samuele Cortese
The efficacy of meditation-based therapies for attention deficit/hyperactivity disorder (ADHD) across the lifespan remains uncertain. To conduct a systematic review and meta-analysis of randomised controlled trials (RCTs) assessing the efficacy of meditation-based therapies for ADHD core symptoms and associated neuropsychological dysfunctions in children/adolescents or adults with ADHD. We...
Evidence-Based Mental Health
May 31, 2016
P. Šóš
There is increasing evidence that some glutamatergic drugs could have antidepressant effects. Ketamine as a promising prototype for novel glutamatergic antidepressants has a much faster onset of action and is possibly more efficacious than standard antidepressants.1 Two recent systematic reviews and meta-analyses assessed the antidepressant efficacy (including modes of administration, duration...
Evidence-Based Mental Health
May 2016
Jaclyn Schwartz, James W. Murrough, Dan V. Iosifescu
Approximately one-third of patients with major depressive disorder (MDD) do not respond to existing antidepressants, and those who do generally take weeks to months to achieve a significant effect. There is a clear unmet need for rapidly acting and more efficacious treatments. We will review recent developments in the study of ketamine, an old anaesthetic agent which has shown significant...